ChemicalBook > Product Catalog >Biochemical Engineering >Plant extracts >Plant Extracts >DL-Laudanosine

DL-Laudanosine

DL-Laudanosine Suppliers list
Company Name: Meryer (Shanghai) Chemical Technology Co., Ltd.  
Tel: 4006356688 18621169109
Email: market03@meryer.com
Company Name: Bide Pharmatech Ltd.  
Tel: 400-164-7117 18317119277
Email: product02@bidepharm.com
Company Name: Quality Control Solutions Ltd.  
Tel: 0755-66853366 13670046396
Email: orders@qcsrm.com
Company Name: Jiangsu Aikon Biopharmaceutical R&D co.,Ltd.  
Tel: 025-66028182 17714375163
Email: yftan@aikonchem.com
Company Name: Alfa Chemistry  
Tel: 1-516-6625404
Email: support@alfa-chemistry.com

DL-Laudanosine manufacturers

  • DL-Laudanosine
  • DL-Laudanosine pictures
  • $42.00
  • 2026-06-02
  • CAS:1699-51-0
  • Purity: 98.90%
  • Supply Ability: 10g
DL-Laudanosine Basic information
Product Name:DL-Laudanosine
Synonyms:(+-)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-veratrylisoquinoline;(+-)-laudanosine;2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-veratryl-(+-)-isoquinolin;N-METHYLTETRAHYDROPAPAVERINE;DL-LAUDANOSIDE;DL-LAUDANOSINE;(+/-)-LAUDANOSIDE;(±)-1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methylisoquinoline
CAS:1699-51-0
MF:C21H27NO4
MW:357.44
EINECS:216-923-9
Product Categories:
Mol File:1699-51-0.mol
DL-Laudanosine Structure
DL-Laudanosine Chemical Properties
Melting point 115°C
Boiling point 490.07°C (rough estimate)
density 1.1729 (rough estimate)
refractive index 1.5614 (estimate)
storage temp. Store at -20°C
solubility DMSO : 100 mg/mL (279.77 mM)
pka7.80±0.40(Predicted)
form Solid
color White to Light Beige
Major Applicationpharmaceutical
Cosmetics Ingredients FunctionsSKIN CONDITIONING
InChIInChI=1S/C21H27NO4/c1-22-9-8-15-12-20(25-4)21(26-5)13-16(15)17(22)10-14-6-7-18(23-2)19(11-14)24-3/h6-7,11-13,17H,8-10H2,1-5H3
InChIKeyKGPAYJZAMGEDIQ-UHFFFAOYSA-N
SMILESC1(CC2=CC=C(OC)C(OC)=C2)C2=C(C=C(OC)C(OC)=C2)CCN1C
LogP3.630 (est)
Safety Information
Risk Statements 26/28-40
Safety Statements 22-24/25
RIDADR 2810
WGK Germany WGK 3
HazardClass 6.1(b)
PackingGroup III
Storage Class11 - Combustible Solids
MSDS Information
DL-Laudanosine Usage And Synthesis
DescriptionThis opium alkaloid occurs in the liquor following precipitation of Thebaine (q.v.) and is purified by extraction with small quantities of Et20, followed by precipitation with potassium iodide. The base crystallizes from hot C6H6 in small, colourless needles and has [α]15D+ 103.23° (EtOH). It is freely soluble in CHCI3, EtOH, Et20 or hot C6H6 but insoluble in H20 or alkalies. No colour is produced with FeCl 3 but with Fe203 and H2S04, a brown colour is formed, changing to green when warmed to ISOoC. With concentrated H2S04 alone, the alkaloid gives a rose-red colour, changing to deep violet at ISO°C. The solution of the alkaloid in EtOH is alkaline to litmus and both it, and its salts, are bitter to the taste. The crystalline methiodide has m.p. 218-221°C; [α]D + 120°. The oxidation products with Mn02 and H2S04 are veratraldehyde, 2:3:6:7- tetramethoxy-9: I O-dihydroanthracene and laudaline (4: S-dimethoxy-2: - methylaminoethylbenzaldehyde, m.p. 123-4°C. On exhaustive methylation it yields trimethylamine and laudanosene (tetramethoxy-o-vinylstilbene). Laudanosine is one of the most convulsant of the opium alkaloids but possesses only a slight analgesic action.
Chemical Propertieslight yellow fine crystalline powder
UsesDL-Laudanosine is an intermediate in synthesizing (S)-Laudanosine (L178525), a metabolite of the neuromuscular-blocking drugs Atracurium (A794500) and Cisatracurium (C496700) with potentially toxic systemic effects. It crosses the blood-brain barrier and may cause excitement and seizure activity.
DefinitionChEBI: 1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinoline is a member of isoquinolines.
Purification MethodsCrystallise these from EtOH. The (±)-picrate crystallises from EtOH with m 177-178o. The (-)-isomer has m 83-85o and
ReferencesPictet, Athanasescu., Ber., 33, 2347 (1900)
Pictet, Finkelstein., ibid, 42, 1979 (1909)
Pyman, Reynolds.,J. Chern. Soc., 97, 1324 (1910)
Kondo, Mori.,J. Ph arm. Soc., Japan, 51,615 (1931)
Craig, Tarbell., J. Amer. Chern. Soc., 70,2783 (1948)
Synthesis:
Pictet, Finkelstein., Compt. rend., 148,925 (1909)
Elliot.,J. Heterocycl. Chern., 7, 1229 (1970)
Pharmacology:
Zunz., Elements de Pharmacodynamie speciale, Tome I, 178, Masson & Co., Paris (1932)
Krueger, Eddy, Sumwalt., U.S. Public Health Reports, Suppl. 165, 1007 (1943)
DL-Laudanosine Preparation Products And Raw materials
Preparation Productslaudanosine
Tag:DL-Laudanosine(1699-51-0) Related Product Information
Atracurium Impurity 18 Cistracurium Besylate EP Impurity D Atracurium Impurity 26 Besylate Atracurium Impurity 41 Atracurium Impurity 1 Atracurium Impurity 19 R-tetrahydropapaverine HCl 1,5-pentanediyl bis[1-[(3,4-dimethoxyphenyl)methyl]-3,4-dihydro-6,7-dimethoxy-1H-isoquinoline-2-propionate] AtracuriuM IMpurity V 6,7-Dimethoxy-2-methyl-1-(3,4,5-trimethoxybenzyl)-1,2,3,4-tetrahydroisoquinoline hydrochloride (1R,2R)-1-[(3,4-Dimethoxyphenyl)methyl]-2-[3-(tert-butoxy)-3-oxopropyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methylisoquinolinium benzenesulfonate Atracurium EP Impurity D Phenyl p-tolyl sulfone Levonorgestrel Glycidol DL-LAUDANOSINE Atracurium besylate Cepharanthine DL-Laudanosoline hydrobromide trihydrate